A study of colorectal cancer screening using stool DNA-based SDC2 methylation test
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Enrollment
1,210
A diagnostic device measuring syndecan 2 methylation status in stool DNA to detect colorectal cancer
Busan Hangun Hospital
Busan, South Korea
Koo Hospital
Daegu, South Korea
Severance Hospital, Yonsei University College of Medicine
Seoul, South Korea
Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine
Seoul, South Korea
SDC2 methylation in stool DNA
positive ratio of SDC2 methylation
Time frame: 1 year
sensitivity and specificity of EarlyTect
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Dea Hang Hospital
Seoul, South Korea
Eunpyeong St. Mary's Hospital
Seoul, South Korea
Seoul Songdo Hospital
Seoul, South Korea
St. Vincent's Hospital, The Catholic University of Korea
Suwon, South Korea